We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Lonza Stretches Transfection Dimensions – Launch of 4D-Nucleofector® System

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Lonza Stretches Transfection Dimensions – Launch of 4D-Nucleofector® System"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Lonza’s new 4D-Nucleofector® System is lifting the Amaxa® Nucleofector® Technology to the next dimension. In response to comprehensive user feedback Lonza engineers and scientists have developed a system which is designed for maximum flexibility.

This Nucleofection® Platform allows transfection of cells in various formats and throughputs using the same Nucleofection® Conditions. 100 µl single Nucleocuvettes® are suited for high cell numbers at low throughput while 20 µl 16-well Nucleocuvette® Strips enable transfection of low cell numbers at medium throughput.

Furthermore, primary neurons can now be transfected at later developmental stages by Nucleofection® in adherence. Being a modular tool, the 4D-Nucleofector® System is designed to be prepared for upcoming transfection challenges.

Nucleofection® is known as the first efficient non-viral transfection method for primary cells and difficult-to-transfect cell lines.